CBR-DIGOXIN ANTISERUM— 510(k) K780498
Substantially EquivalentClinical Bioresearch
FDA 510(k) clearance K780498 for CBR-DIGOXIN ANTISERUM, Substantially Equivalent on 1978-04-05. Applicant: Clinical Bioresearch. Device class: 2.
Clearance details
- Applicant
- Clinical Bioresearch
- Product code
- Code DKA
- Device class
- Class 2
- Regulation
- 21 CFR 862.3320
- Advisory panel
- Clinical Toxicology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Mchenry, IL, US
Recent devices under product code DKA
view allMore clearances from Clinical Bioresearch
view allData sourced from openFDA. This site is unofficial and independent of the FDA.